OTTLIV names winners of first Innovation Trophies

Monday, July 2, 2012 12:04 PM

OTTLIV, the technology transfer arm of Assistance Publique-Hopitaux de Paris (AP-HP), a network of 37 Paris hospitals and universities, has announced the results of the first Innovation Trophies, designed to mark outstanding promise resulting from research within AP-HP.

The “Promising Patent” award went to Antoine Carpentier, Hopital Avicenne, for his research on cerebral tumors and one of 115 patents considered. The “Promising Start-up” trophy, a category of 45 companies, was awarded to his brother, Alexandre Carpentier, from the Hopital Salpetriere, founder of Carthera, a developer of therapeutic ultrasound devices and intra-articular ultrasound implants.

The awards were organized jointly between AP-HP, CDC Entreprises—an arm of the French government’s Caisse des Depots, investing in more than 3,000 small and medium companies in France—and INPI, France’s intellectual property and patent office.

“Now we have established these Innovation Trophies, we want to give all the encouragement we can to entrepreneurs and project leaders from AP-HP so as to create a new generation of viable enterprises that will stay the course,” said Florence Ghrenassia, director of OTTLIV. “The awards will raise their profile and help generate support from a variety of sources including early stage financing and intellectual property advice, all of which will help them deploy their talents and, we hope, enjoy a flourishing business.”

“The variety of innovations and patents coming out of AP-HP is unbelievable,” added Annick Schwebig, president of the Innovation Trophies jury. “It is a highly diversified source of new tools and treatments for future patients.”

Share:          
CWWeekly

March 30

Icon, Carnegie Mellon partner to research ways to improve study patients' understanding of Informed Consent

Veeva launches OpenKey, partner program to unlock difficult access to, restrictions on customer reference data

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

March

Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

February

Study grants market breaks $13 billion
Volume of clinical activity rising while growth in grant spending slows

Revisiting eClinical Technology Solutions Adoption
While use of established solutions grows, sponsors hesitate on newer tools

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs